Therapeutic indications & presentation
Symbicort (budesonide/formoterol) Turbohaler is indicated for adults, adolescents 12 years and older and children aged 6 years and older (100/6 only) for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting ß2-adrenoceptor agonist) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting ß2-adrenoceptor agonists or
- Patients already adequately controlled on both inhaled corticosteroids and long acting ß2-adrenoceptor agonists.1-3
Symbicort Turbohaler, all strengths, can be used as regular maintenance therapy only in adults, adolescents 12 years and older and children aged 6 years and older (100/6 only).1-3
Symbicort Turbohaler 200/6 and 100/6 can also be used for Symbicort Maintenance and Reliever Therapy in adults and adolescents 12 years and older.1,2
See Summary of Product Characteristics for further information.